The largest database of trusted experimental protocols

Prisma

Prisma is an innovative AI-driven platform developed by PubCompare.ai that enhances research workflows.
It enables users to leverge protocol comparisons across literature, preprints, and patents to identify the best methodologies.
Prisma's tools help optimize experiments and improve reproducibility, streamlining the research process.

Most cited protocols related to «Prisma»

We used the following search terms to identify scholarly articles containing frameworks of behaviour change interventions: Topic = (taxonomy or framework or classification) AND Topic = ('behaviour change' or 'behavior change') AND Topic = (prevention OR intervention OR promotion OR treatment OR program OR programme OR policy OR law OR politics OR regulation OR government OR institute OR legislation).
Searches of Web of Science (Science and Social Science databases), Pubmed. and PsycInfo were supplemented by consulting with eight international experts in behaviour change, drawn from the disciplines of psychology, health promotion, epidemiology, public health, and anthropology. Given that there may be frameworks described in books and non peer-reviewed articles, we acknowledged that it was unlikely that we would arrive at a complete set, but we sought to canvass enough to be able to undertake an analysis of how well as a whole they matched the criteria described earlier and to achieve sufficient coverage of the key concepts and labels.
Documents were included if: they described a framework of behaviour change interventions (not specific behaviour change techniques); the framework was specified in enough detail to allow their key features to be discerned; and they were written in English. They were originally selected on the basis of titles and abstracts. A subset was then selected using the inclusion criteria for full review. The nature of the topic meant that this review could not be undertaken using the PRISMA guidelines [21 ].
Once the frameworks were identified, their categories and category definitions were extracted and tabulated. This was done independently by MS and a researcher who was not part of the study team or familiar with this work. The frameworks were coded according to the criteria for usefulness by RW and SM.
Full text: Click here
Publication 2011
Behavior Therapy Health Promotion prisma
In the absence of empirical evidence, the present COSMIN guideline for systematic reviews of PROMs is based on our experience that we (that is: the COSMIN steering committee) have gained over the past years in conducting systematic reviews of PROMs [11 (link), 12 (link)], in supporting other systematic reviewers in their work [13 (link), 14 (link)], and in the development of COSMIN methodology [15 (link), 16 (link)]. In addition, we have studied the quality of systematic reviews of PROMs in two consecutive reviews [7 (link), 17 (link)], and in reviews that have used the COSMIN methodology we have specifically searched for the comments made by review authors relating to the COSMIN methodology. Further, we have had iterative discussions by the COSMIN steering committee, both at face-to-face meetings (CP, WM, HdV and CT) and by email. We gained experience from results of a recent Delphi study on the content validity of PROMs [18 ], and from results of a previous Delphi study on the selection of outcome measurement instruments for outcomes included in core outcome sets (COS) [19 (link)]. Further, the guideline was developed in concordance with existing guidelines for reviews, such as the Cochrane handbook for systematic reviews of interventions [20 ] and for diagnostic test accuracy reviews [21 ], the PRISMA Statement [22 ], the Institute of Medicine standards for systematic reviews of comparative effectiveness research [23 ], and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) principles [24 ].
Full text: Click here
Publication 2018
Face prisma Tests, Diagnostic
The present review focuses on 11 key methodological issues related to GT3X/+ data collection and processing criteria: (1) device placement, (2) sampling frequency, (3) filter, (4) epoch length, (5) non-wear-time definition, (6) what constitutes a valid day and a valid week, (7) registration period protocol, (8) SED and PA intensity classification, (9) PAEE algorithms, (10) sleep algorithms, and (11) step counting. Available information was classified into two different types of studies: (1) any cross-sectional, longitudinal, or intervention study which used the GT3X/+ device and met the inclusion criteria indicated in Sect. 2.3 (objective 1); and (2) studies focused on validation, calibration, or comparison of functions related to data collection or processing criteria (objective 2). Therefore, the practical considerations provided for each age group are based on the results from the validation/calibration studies (see Table 1). Furthermore, we provide a summary of all data extracted from the validation/calibration papers included in this review by age group in the Electronic Supplementary Material Appendix S1. Inclusion/exclusion criteria and analytical methods were specified in advance and registered in the PROSPERO (http://www.crd.york.ac.uk/PROSPERO/) international database of systematic reviews (CRD42016039991) [32 (link)]. The study is conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [33 (link)].
Publication 2017
Age Groups EPOCH protocol GZMB protein, human Medical Devices Sleep

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Adult Brain Electricity Head prisma Radionuclide Imaging
Data were extracted from each paper with customised data extraction forms. Attempts were made to retrieve missing data after contacting the corresponding author. Missing variance measures were imputed using published formulas [23 ]. Three reviewers independently assessed the risk of bias of each of the included studies and discussed their assessments to achieve consensus. A score for quality, modified from the Newcastle-Ottawa scale, was used to assess appropriateness of research design, recruitment strategy, response rate, representativeness of sample, objectivity/reliability of outcome determination, power calculation provided, and appropriate statistical analyses. Score disagreements were resolved by consensus and a final agreed-upon rating was assigned to each study. We used the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) statement for reporting systematic reviews and meta-analyses as a guide for this study (S1 Text) [24 (link)], including the preparation of a protocol and analysis plan (S2 Text).
Full text: Click here
Publication 2016
Diet, Formula prisma

Most recents protocols related to «Prisma»

The original PRISMA-7 questionnaire consists of seven questions related to the risk factors for frailty [14 (link)]. Every “yes” response contributes to a point; an individual with more than three positive responses (3 “yes”) is considered at risk of frailty. A well-validated screening tool for frailty [15 (link)], it has good sensitivity (78.3%) and specificity (74.4%) [14 (link)].
Full text: Click here
Publication 2024
The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) protocol [13 (link)] was employed for this review to ensure a systematic and transparent approach to conducting the review and reporting its findings. It guided the reporting of the results in a structured and transparent manner, adhering to the PRISMA flowchart to illustrate the study selection process (Fig. 1). The systematic presentation of the findings included forest plots, summary tables, and comprehensive descriptions of the main outcomes.

PRISMA protocol representation for the review

Full text: Click here
Publication 2024
The PRISMA standard (Preferred Reporting Items for Systematic Reviews and Meta‐analyses) was developed by Moher et al.
29 (link) as well, and the procedures referred by Hoque et al.
30 and Hanvold et al.
31 (link) are the foundations for this investigation. It can direct researchers as they formulate precise answers to study inquiries. Identification, screening, establishing inclusion and exclusion standards, determining eligibility, quality evaluation, data collection, abstraction, and analysis are all included in the systematic search methods used by Ishtiaque et al.
32  Our systematic review fully adheres to the PRISMA guidelines (Table 1).
Full text: Click here
Publication 2024
The translation and cross-cultural adaptation process of the PRISMA-7 questionnaire were adopted from Brislin’s translation model and followed the guidelines provided by the American Association of Orthopaedic Surgeons [29 (link), 30 (link)]. Figure 1 depicts the five-phased translation and cross-cultural adaptation process to develop the Chinese PRISMA-7 questionnaire. Four independent translators, fluent in English and Chinese and familiar with the PRISMA-7 questionnaire, performed the forward translation of the original questionnaire from English to Chinese (Versions A to D). The four versions were compared and referenced to synthesise the interim forward translated version E. Two physiotherapists, who were not involved with the initial forward translations, reviewed and adjusted the overall presentation of the interim questionnaire to formulate version F. Subsequently, the backward translation was performed from Chinese (version F) to English (Version G1 to G20), by 20 laypersons who were colloquially fluent in English and Chinese, but with no prior knowledge of the PRISMA-7 questionnaire. The 20 laypersons, aged 18 to 45 years, originated from diverse and non-healthcare backgrounds. Lastly, the panel of researchers, which consisted of four investigators and two physiotherapists, reviewed the 20 backwards translated versions for face and content validity. Modifications were made as necessary to produce the final Chinese PRISMA-7 questionnaire (Version H). The determination of face and content validity took place during the translation and developmental process of the Chinese PRISMA-7.

Flow diagram of the translation and cross-cultural adaptation process

Full text: Click here
Publication 2024
The PRISMA approach has four steps for document analysis under 27 checklists (S1 Table) [32 (link)]. In the Identification phase, researchers cast a wide net, seeking out an array of records through comprehensive database searches and other ancillary sources. This phase is the foundation, ensuring a robust and exhaustive initial collection of potential materials for review. Subsequently, in the Screening phase, there’s a sifting process wherein researchers engage in a preliminary evaluation. At this juncture, titles and abstracts of articles are scrutinized to filter out studies that don’t align with the thematic core of the review. It’s a crucial phase that ensures the research stays focused and relevant. The third phase, Eligibility, demands a deeper dive. Researchers engage with the full-text versions of the remaining articles to further determine their pertinence and fit. It’s not merely about surface alignment but an in-depth evaluation of each study’s content, methodology, and outcomes to gauge its suitability for inclusion. Lastly, the Inclusion phase is the culmination of this rigorous process. Here, the final set of studies that have successfully passed through the crucible of the prior phases and unequivocally meet the specified criteria find their place in the systematic review.
Full text: Click here
Publication 2024

Top products related to «Prisma»

Sourced in Germany, United States, Switzerland
The MAGNETOM Prisma is a magnetic resonance imaging (MRI) system designed and manufactured by Siemens. It is a powerful diagnostic imaging device that uses strong magnetic fields and radio waves to generate detailed images of the human body. The MAGNETOM Prisma is capable of providing high-quality, high-resolution imaging data to support clinical decision-making and patient care.
Sourced in Germany, United States
The Prisma is a versatile laboratory equipment designed for a wide range of scientific applications. It serves as a reliable tool for various analytical and research processes. The core function of the Prisma is to provide accurate and consistent results through its advanced technology and precise measurements.
Sourced in Germany, United States
The Prisma scanner is a high-performance medical imaging device designed for magnetic resonance imaging (MRI) applications. It features advanced hardware and software capabilities that enable efficient and reliable data acquisition for a wide range of clinical examinations.
Sourced in Germany
The Prisma 3T scanner is a magnetic resonance imaging (MRI) system manufactured by Siemens. It is designed to provide high-quality images of the human body. The Prisma 3T scanner operates at a magnetic field strength of 3 Tesla, allowing for enhanced image resolution and detail.
Sourced in Germany, United States, Australia, United Kingdom, Canada
The 32-channel head coil is a key component in magnetic resonance imaging (MRI) systems. It is designed to acquire high-quality images of the human head, enabling detailed visualization and analysis of brain structure and function.
Sourced in Germany
The 64-channel head coil is a specialized piece of medical imaging equipment designed for use in magnetic resonance imaging (MRI) scanners. Its primary function is to transmit and receive radiofrequency (RF) signals from the human head during MRI examinations, enabling high-quality imaging of the brain and associated structures.
Sourced in Germany
The 3T Prisma is a magnetic resonance imaging (MRI) system manufactured by Siemens. It operates at a field strength of 3 Tesla, providing high-resolution imaging capabilities. The core function of the 3T Prisma is to generate detailed images of the body's internal structures for diagnostic and research purposes.
Sourced in United States
Prisma is a powerful graphing and data analysis software designed for scientific and research applications. It allows users to create high-quality graphs and visualizations from their data, with a wide range of graph types and customization options.
Sourced in Germany
Prisma Fit is a piece of laboratory equipment designed for spectroscopic analysis. It functions as a spectrometer, capable of measuring the absorption or emission spectra of samples. The core purpose of the Prisma Fit is to provide precise and accurate spectroscopic data for research and analytical applications.
Sourced in Germany, United States, United Kingdom, China
The Tim Trio is a versatile laboratory equipment that serves as a temperature-controlled magnetic stirrer. It features three independent stirring positions, allowing simultaneous operation of multiple samples. The device maintains a consistent temperature range to ensure accurate and reliable results during experimental procedures.

More about "Prisma"

Prisma is a cutting-edge AI-driven platform developed by PubCompare.ai that streamlines the research process.
It enables users to leverage protocol comparisons across literature, preprints, and patents to identify the best methodologies.
Prisma's innovative tools help optimize experiments and improve reproducibility, ensuring efficient and reliable research workflows.
Beyond the Prisma platform, there are other related terms and technologies worth exploring.
The MAGNETOM Prisma is a high-performance 3T MRI scanner that offers exceptional image quality and advanced capabilities.
The Prisma scanner and Prisma 3T scanner are powerful imaging solutions used in various clinical and research settings.
The 32-channel and 64-channel head coils are specialized accessories that enhance the performance of Prisma scanners, providing superior signal-to-noise ratio and image resolution.
The Prisma Fit is a configurable version of the Prisma scanner, tailored to meet the unique needs of different research and clinical environments.
Additionally, the Tim Trio system is a predecessor to the Prisma, offering a robust 3T MRI platform with advanced features and capabilities.
These technologies, when combined with the insights and tools provided by the Prisma platform, can contribute to a more streamlined and effective research workflow, leading to improved experimental outcomes and enhanced reproducibility.